Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
Prasad N, Derado G, Nanduri S, Reses H, Dubendris H, Wong E, Soe M, Li Q, Dollard P, Bagchi S, Edwards J, Shang N, Budnitz D, Bell J, Verani J, Benin A, Link-Gelles R, Jernigan J, Pilishvili T. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022. MMWR Morbidity And Mortality Weekly Report 2022, 71: 633-637. PMID: 35511708, PMCID: PMC9098239, DOI: 10.15585/mmwr.mm7118a4.Peer-Reviewed Original ResearchMeSH KeywordsBNT162 VaccineCOVID-19COVID-19 VaccinesHumansMRNA VaccinesNursing HomesSARS-CoV-2United StatesVaccines, SyntheticConceptsNational Healthcare Safety NetworkNursing home residentsPrimary series vaccinationSkilled nursing facilitiesBooster vaccine doseRelative vaccine effectivenessBooster doseVaccine effectivenessHome residentsSeries vaccinationVaccine doseCDC's National Healthcare Safety NetworkPreventing SARS-CoV-2 InfectionCOVID-19COVID-19-associated morbidityEarly COVID-19 vaccinationCOVID-19 vaccine doseSARS-CoV-2 infectionOmicron variant infectionVaccine-induced immunityNursing home staff membersPrimary doseVaccination coverage dataCOVID-19 prevention strategiesCOVID-19 vaccination